The factor structure of the Mystical Experience Questionnaire (MEQ): Reply to Bouso et al., 2016 January 25, 2017
The factor structure of the Mystical Experience Questionnaire (MEQ): Reply to Barrett & Griffiths (2016) January 25, 2017
The factor structure of the Mystical Experience Questionnaire (MEQ): Reply to Barrett & Griffiths (2016) January 25, 2017
Reply to: Ketamine and Psychosis History: Antidepressant Efficacy and Psychotomimetic Effects Postinfusion January 23, 2017
Tackling Harm Reduction, Human Rights and Drug Uses on Recreational Environments: Tensions, Potentialities and Learnings from the Kosmicare Project (Portugal) January 16, 2017
Weak phantasy and visionary phantasy: the phenomenological significance of altered states of consciousness January 3, 2017
Ketamine for the treatment of major depressive disorder and bipolar depression: A review of the literature January 1, 2017
